https://scholars.lib.ntu.edu.tw/handle/123456789/583122
標題: | Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates | 作者: | Wang C.-M. Lai C.-C. Tan C.-K. Huang Y.-C. KUEI-PIN CHUNG MENG-RUI LEE Hwang K.-P. PO-REN HSUEH |
公開日期: | 2012 | 卷: | 72 | 期: | 3 | 起(迄)頁: | 199-203 | 來源出版物: | Diagnostic Microbiology and Infectious Disease | 摘要: | Human infections due to Roseomonas species are uncommon and the vast majority of reported infections are opportunistic and easy to treat. We retrospectively reviewed the computerized database of the Bacteriology Laboratory at the National Taiwan University Hospital to identify patients with infections caused by Roseomonas species during the period January 2000 to December 2010. Isolates of Roseomonas species were confirmed by 16S rRNA gene sequencing analysis. During the study period, 20 patients had cultures positive for Roseomonas species. R. mucosa was the most prevalent isolate (n = 18), followed by 1 each of R. gilardii and Roseomonas genomospecies 5. True infection caused by Roseomonas species was confirmed in 17 (85%) patients. Most (n = 12, 71%) of these infections were health care-associated infection. The majority of the patients (n = 12, 71%) had underlying diseases. Malignancy was the most common underlying disease, and catheter-related bloodstream infection was the most common type of infection. The antimicrobial susceptibility patterns varied among the different Roseomonas species. In conclusion, Roseomonas species can cause infection in children and adults regardless of immune status. Because different Roseomonas species may have different clinical features and susceptibility profiles, molecular studies are necessary to identify Roseomonas isolates to the species level. ? 2012 Elsevier Inc.. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856618283&doi=10.1016%2fj.diagmicrobio.2011.11.013&partnerID=40&md5=2923482db9e61b71a9894b739277555b https://scholars.lib.ntu.edu.tw/handle/123456789/583122 |
ISSN: | 0732-8893 | DOI: | 10.1016/j.diagmicrobio.2011.11.013 | SDG/關鍵字: | amikacin; amoxicillin plus clavulanic acid; antibiotic agent; aztreonam; cefepime; cefotaxime; ceftazidime; ciprofloxacin; clavulanic acid; colistin; ertapenem; gentamicin; imipenem; levofloxacin; piperacillin; piperacillin plus tazobactam; RNA 16S; sultamicillin; tazobactam; ticarcillin; tigecycline; vancomycin; adult; aged; antibiotic sensitivity; article; bacteremia; bacterium culture; bacterium isolate; catheter infection; cellulitis; clinical article; controlled study; female; gene sequence; Gram negative bacterium; Gram negative infection; hospital infection; human; male; minimum inhibitory concentration; nonhuman; nucleotide sequence; priority journal; retrospective study; Roseomonas genomospecies; Roseomonas gilardii; Roseomonas infection; Roseomonas mucosa; sequence analysis; soft tissue infection; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Methylobacteriaceae; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。